SharesGrow 7-Criteria Score
All 7 criteria scored · valuation-related highlighted on this page
MedTech Acquisition Corporation (MTACW) .
Criteria proven by this page:
- VALUE (0/100, Fail) — the composite valuation score falls below the 60/100 threshold required to pass.
Overall SharesGrow Score: 35/100 with 1/7 criteria passed.
SharesGrow 7-Criteria Score
~
HEALTH
50/100
Debt-to-Equity & liquidity
→ Health
Valuation Snapshot — MTACW
Valuation Multiples
P/E (TTM)0.0
Forward P/EN/A
PEG RatioN/A
Forward PEGN/A
P/B Ratio0.00
P/S Ratio0.18
EV/EBITDA0.0
Per Share Data
EPS (TTM)$-1.84
Book Value / Share$0.00
Revenue / Share$1.19
FCF / Share$0.00
Yields & Fair Value
Earnings YieldN/A
Dividend Yield0.00%
P/E Ratio & Earnings Yield
Earnings Per Share (EPS) History
| Year |
EPS (Diluted) |
Revenue |
Net Income |
Net Margin |
| 2020 |
$-1.04 |
$5.43M |
$-31.83M |
-585.8% |
| 2021 |
$-0.92 |
$8.4M |
$-28.85M |
-343.4% |
| 2022 |
$-1.59 |
$12.4M |
$-47.19M |
-380.6% |
| 2023 |
$-2.23 |
$18.51M |
$-59.04M |
-318.9% |
| 2024 |
$-1.25 |
$29.43M |
$-33.23M |
-112.9% |
| 2025 |
$-1.84 |
$45.15M |
$-39.23M |
-86.9% |
